Literature DB >> 19374211

Ephedrine versus phenylephrine: prevention of hypotension during spinal block for cesarean section and effects on the fetus.

Edno Magalhães1, Catia Sousa Govêia, Luís Cláudio de Araújo Ladeira, Bruno Góis Nascimento, Sérgio Murilo Cavalcante Kluthcouski.   

Abstract

BACKGROUND AND OBJECTIVES: Hypotension during spinal block for cesarean section is secondary to the sympathetic blockade and aorto-caval compression by the uterus and it can be deleterious to both the fetus and the mother. Ephedrine and phenylephrine improve venous return after sympathetic blockade during the spinal block. The objective of this study was to compare the efficacy of ephedrine and phenylephrine in the prevention and treatment of maternal hypotension during spinal block and to evaluate their side effects and fetal changes.
METHODS: Sixty patients undergoing spinal block with bupivacaine and sufentanil for cesarean section were randomly divided in two groups to receive prophylactic ephedrine (Group E, n = 30, dose = 10 mg) or phenylephrine (Group P, n = 30, dose = 80 microg). Hypotension (blood pressure equal or lower than 80% of baseline values) was treated with bolus administration of the vasoconstrictor at 50% of the initial dose. The incidence of hypotension, reactive hypertension, bradycardia, and vomiting, and Apgar scores on the 1st and 5th minutes, and blood gases of the umbilical cord blood were evaluated.
RESULTS: The mean dose of ephedrine used was 14.8 +/- 3.8 mg and of phenylephrine was 186.7 +/- 52.9 microg. Demographic parameters and the incidence of vomiting, bradycardia, and reactive hypertension were similar in both groups. Hypotension had an incidence of 70% in Group E and 93% in Group P (p < 0.05). The mean arterial pH of the umbilical cord blood and the Apgar score in the 1st minute were lower in Group E (p < 0.05). Differences in the Apgar score in the 5th minute were not observed.
CONCLUSIONS: Ephedrine was more effective than phenylephrine in the prevention of hypotension. Both drugs had similar incidence of side effects. Fetal repercussions were less frequent with phenylephrine and were transitory with the use of ephedrine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374211     DOI: 10.1590/s0034-70942009000100003

Source DB:  PubMed          Journal:  Rev Bras Anestesiol        ISSN: 0034-7094            Impact factor:   0.964


  6 in total

1.  Vasopressor choice for hypotension in elective Cesarean section: ephedrine or phenylephrine?

Authors:  Chandrakala P Gunda; Jennifer Malinowski; Aruna Tegginmath; Venkatesh G Suryanarayana; Sathees B C Chandra
Journal:  Arch Med Sci       Date:  2010-04-30       Impact factor: 3.318

2.  Techniques for preventing hypotension during spinal anaesthesia for caesarean section.

Authors:  Cheryl Chooi; Julia J Cox; Richard S Lumb; Philippa Middleton; Mark Chemali; Richard S Emmett; Scott W Simmons; Allan M Cyna
Journal:  Cochrane Database Syst Rev       Date:  2020-07-01

3.  Comparing prophylactic effect of phenylephrine and ephedrine on hypotension during spinal anesthesia for hip fracture surgery.

Authors:  Rahman Abbasivash; Shahryar Sane; Mitra Golmohammadi; Shahram Shokuhi; Fereshteh Danaye Toosi
Journal:  Adv Biomed Res       Date:  2016-10-26

4.  Comparing slow and rapid bolus of ephedrine in pregnant patients undergoing planned cesarean section under spinal anesthesia.

Authors:  Prabu Gunasekaran; Lenin Babu Elakkumanan; Hemavathi Balachander; M V S Satyaprakash
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Jan-Mar

5.  A Randomized Double-Blinded Dose-dependent Study of Metaraminol for Preventing Spinal-Induced Hypotension in Caesarean Delivery.

Authors:  Fei Xiao; Wen-Ping Xu; Han-Qing Yao; Jia-Ming Fan; Xin-Zhong Chen
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

6.  The Effect of Prophylactic Infusion of Combined Ephedrin and Phenylephrine on Maternal Hemodynamic after Spinal Anesthesia for Cesarean Section: A Randomized Clinical Trial.

Authors:  Simin Atashkhoie; Hojat Pourfathi; Bahman Naghipour; Shahla Meshgi
Journal:  Iran J Med Sci       Date:  2018-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.